INFANRIX IPV+HIB VACCINE
Product details
Registration number: SIN10988P
Classification: Prescription Only
Active ingredients:
- DIPHTHERIA TOXOID (D)
- FILAMENTOUS HAEMAGGLUTININ (FHA)
- HIB PURIFIED CAPSULAR POLYSACCHARIDE
- PERTACTIN (PRN or 69kDa Outer Membrane Protein)
- PERTUSSIS TOXOID (PT)
- POLIO VIRUS TYPE 1 (INACTIVATED)
- POLIO VIRUS TYPE 2 (INACTIVATED)
- POLIO VIRUS TYPE 3 (INACTIVATED)
- TETANUS TOXOID (T)
Strength:
- min 30IU/0.5ml
- 25mcg/0.5ml
- 10 mcg/0.5 ml
- 8mcg/0.5ml
- 25mcg/0.5ml
- 40DU/0.5ml
- 8DU/0.5ml
- 32DU/0.5ml
- min 40IU/0.5ml
Dosage form: INJECTION
Route: INTRAMUSCULAR
Registrant: GLAXOSMITHKLINE PTE LTD
ATC code: J07CA06
HSA approval date: 25 June 1999
Manufacturer(s):
- GlaxoSmithKline Biologicals
- GlaxoSmithKline Biologicals SA
Manufacturing country/countries: FRANCE; BELGIUM
What are the HSA registration number and classification for INFANRIX IPV+HIB VACCINE?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN10988P
Classification: Prescription Only
What active ingredients and strength are recorded for INFANRIX IPV+HIB VACCINE?
According to the HSA dataset updated 7 August 2026:
Active ingredients:
- DIPHTHERIA TOXOID (D)
- FILAMENTOUS HAEMAGGLUTININ (FHA)
- HIB PURIFIED CAPSULAR POLYSACCHARIDE
- PERTACTIN (PRN or 69kDa Outer Membrane Protein)
- PERTUSSIS TOXOID (PT)
- POLIO VIRUS TYPE 1 (INACTIVATED)
- POLIO VIRUS TYPE 2 (INACTIVATED)
- POLIO VIRUS TYPE 3 (INACTIVATED)
- TETANUS TOXOID (T)
Strength:
- min 30IU/0.5ml
- 25mcg/0.5ml
- 10 mcg/0.5 ml
- 8mcg/0.5ml
- 25mcg/0.5ml
- 40DU/0.5ml
- 8DU/0.5ml
- 32DU/0.5ml
- min 40IU/0.5ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for INFANRIX IPV+HIB VACCINE?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: INTRAMUSCULAR
Who is the recorded registrant for INFANRIX IPV+HIB VACCINE?
According to the HSA dataset updated 7 August 2026:
Registrant: GLAXOSMITHKLINE PTE LTD
Which manufacturers and countries are listed for INFANRIX IPV+HIB VACCINE?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- GlaxoSmithKline Biologicals
- GlaxoSmithKline Biologicals SA
Manufacturing country/countries: FRANCE; BELGIUM
Where can I look up INFANRIX IPV+HIB VACCINE in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN10988P or the exact product name INFANRIX IPV+HIB VACCINE. The general register link does not preselect this product.
What are the source dates for this INFANRIX IPV+HIB VACCINE record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this INFANRIX IPV+HIB VACCINE record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN10988P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)